Method for evaluating biological efficacy of NK (Natural Killer) cells by utilizing fluorescence detection and effect-target ratio

The fluorescence changes of target cell K562-Luc are identified by the microplate reader, combined with the killing rate of different target ratios, and the safety and accuracy of existing NK cell detection methods are solved, achieving rapid and sensitive NK cell biological efficacy Assessment provides an effective evaluation of NK cell growth inhibition and killing ability.

CN118932007APending Publication Date: 2024-11-12SHENZHEN FIRST CONDOR BIOSCIENCE CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411037466.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing NK cell biological efficacy detection methods have problems such as complex isotope waste treatment, large result errors, cell staining toxicity and safety risks, making it difficult to achieve rapid, safe, accurate and sensitive assessment.

Method used

The chemiluminescence detector of the microplate reader recognizes the fluorescence changes of the target cell K562-Luc, and reflects the biological efficacy of NK cells through the killing rate of different target ratios, providing a simple, fast, high-sensitivity, and high-throughput detection method. The required NK cell samples are small, simple to operate, and low evaluation cost.

Benefits of technology

A high sensitivity, rapid and accurate assessment of the biological efficacy of NK cells is achieved, and the killing rate of different effective target ratios reflects the growth inhibition and killing ability of NK cells on target cells, providing a reliable data reference for immunotherapy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118932007A_ABST
    Figure CN118932007A_ABST
Patent Text Reader

Abstract

The invention discloses a method for evaluating biological efficacy of NK (Natural Killer) cells by utilizing fluorescence detection and an effect-target ratio. The method comprises the following steps: carrying out mixed culture on K562-Luc target cells and the NK cells; after the culture is finished, adding a fluorescein reaction substrate for incubation; after incubation is finished, the biological efficacy of the NK cells is evaluated by detecting a fluorescence detection value and combining an effect-target ratio. According to the method, a target cell strain line capable of stably expressing luciferase is constructed, and fluorescence change of target cells K562-Luc is recognized by combining a chemiluminescence detector of a microplate reader, so that the biological efficacy of the NK cells is simply and quickly detected with high sensitivity and high flux; and moreover, the required NK cell sample size is small, the operation is simple, and the evaluation cost is saved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedical technology, and in particular to a method for evaluating the biological efficacy of NK cells by utilizing fluorescence detection and effector-target ratio. Background Art

[0002] Natural killer cells (NK cells) have a strong killing effect on a variety of tumor cells or infected cells. NK cells are closely related to the occurrence, development and treatment of a variety of diseases. Therefore, by evaluating the biological efficacy of NK cells, we can understand the cellular immune function of different individuals.

[0003] The evaluation of the biological efficacy of NK cells in vitro has important guiding significance for the functional research on cell activity, tumor suppression effect, immunotherapy, etc. in vitro and in vivo. In addition to providing references in basic research, it also provides necessary references for subsequent product development and clinical use.

[0004] Common detection methods for NK cell biological efficacy include 51Cr release experiment, lactate dehydrogenase (LDH) release method, Calcein-AM / PI method, etc. However, these methods have limitations, such as: 51Cr release experiment, isotope waste disposal and experimental protection requirements are high; LDH release method, the result error is large, the repeatability is poor; Calcein-AM / PI (propidium iodide) has poor staining effect on some cells with high nuclear-cytoplasmic ratio, Calcein-AM has different degrees of damage to cell function at high concentrations, and PI has certain toxicity and mutagenicity, which poses safety risks.

[0005] Therefore, providing a convenient, rapid, safe, accurate and sensitive evaluation method to evaluate the biological efficacy of NK cells has positive significance for the evaluation of NK cell function and the development of immunotherapy. Summary of the invention

[0006] The object of the present invention is to provide a method for evaluating the biological efficacy of NK cells in vivo. The method can detect the biological efficacy of NK cells in a simple, rapid, high-sensitivity and high-throughput manner by identifying the fluorescence changes of target cells K562-Luc through a chemiluminescence detector of an ELISA instrument, and requires a small amount of NK cell samples. At the same time, the killing rate of different effect-target ratios reflects the biological efficacy of NK cells, and the growth inhibition and killing ability of NK cells on target cells can be further evaluated.

[0007] A method for evaluating the biological efficacy of natural killer cells in vitro, comprising the following steps:

[0008] (1) Centrifuge NK cells and target cells K562-Luc at room temperature, collect the cells after centrifugation, and dilute them to the cell density with KBM581 medium;

[0009] (2) Count the live NK cells and K562-Luc cells respectively and keep them for later use;

[0010] (3) placing the counted NK cells and K562-Luc cells in the wells of a well plate according to the effector-target ratio and co-culturing them; wherein the effector-target ratio E:T=10:1, 5:1, 1:1, 0.5:1 and 0.1:1;

[0011] (4) After the mixed culture is completed, add the luciferin reaction substrate to the wells of the well plate, mix it by pipetting repeatedly, and incubate it at room temperature in the dark;

[0012] (5) After the incubation, the fluorescence detection value was read on the microplate reader at a wavelength of 570 nm;

[0013] (6) The biological efficacy of NK cells was evaluated by fluorescence detection value and effector-target ratio.

[0014] The NK cell biological efficacy evaluation method of the present invention realizes simple, rapid, highly sensitive and high-throughput detection of the biological efficacy of NK cells by constructing a target cell that can stably express luciferase and combining a chemiluminescence detector of an enzyme reader to identify the fluorescence change of the target cell K562-Luc. The required NK cell sample amount is small, the operation is simple and the evaluation cost is low. At the same time, the biological efficacy of NK cells is reflected by the killing rate of different effector-target ratios, and can be further used to evaluate the growth inhibition and killing ability of NK cells on target cells. BRIEF DESCRIPTION OF THE DRAWINGS

[0015] Figure 1 This is a flow chart for evaluating the biological efficacy of NK cells of the present invention;

[0016] Figure 2 It is a bar graph of the killing rate of Donor 1 NK cells in parallel plate 1 in Example 1;

[0017] Figure 3 It is a bar graph of the killing rate of Donor 1 NK cells in parallel plate 2 in Example 1;

[0018] Figure 4 It is a bar graph of the killing rate of Donor 1 NK cells in parallel plate 3 in Example 1;

[0019] Figure 5 This is a bar graph comparing the killing rates of three plates of Donor 1 NK cells in parallel plates 1-3 in Example 1;

[0020] Figure 6It is a bar graph of the killing rate of Donor 2 NK cells in parallel plate 1 in Example 2;

[0021] Figure 7 It is a bar graph of the killing rate of Donor 3 NK cells in parallel plate 1 in Example 2;

[0022] Figure 8 It is a bar graph of the killing rate of Donor 4 NK cells in parallel plate 1 in Example 2; DETAILED DESCRIPTION

[0023] The preferred embodiments of the present invention are further described in detail below in conjunction with the accompanying drawings.

[0024] like Figure 1 As shown, the method for evaluating the biological efficacy of NK cells provided by the present invention comprises the following steps:

[0025] S1. Obtain K562-Luc target cells and NK cells (also called effector cells) respectively; and count the number of live NK cells and K562-Luc target cells respectively;

[0026] S2. Centrifuge the obtained K562-Luc target cells and NK cells at 200-600 g for 3-6 min respectively;

[0027] S3. After centrifugation, the NK cell precipitate and the K562-Luc target cell precipitate were collected respectively, and the NK cells and K562-Luc cells were resuspended in KBM581 culture medium (NK cell culture medium purchased from Corning) to obtain respective cell suspensions;

[0028] S4. Add the NK cell suspension and K562-Luc target cell suspension to the wells of the well plate according to the set effector-target ratio and place them in an incubator at 37°C and 5% CO2 for co-culture for 3 to 8 hours;

[0029] S5. After the incubation, add the luciferin reaction substrate to each well of the well plate and incubate in the dark for 7 minutes. During the incubation in the dark, you can turn on the microplate reader at the same time. After the instrument passes the self-test, select the emission wavelength of 570nm and the mode of shaking the detection plate before reading.

[0030] After incubation for 6 and 7 minutes, the fluorescence detection value (also known as chemiluminescence value) is read on the machine;

[0031] S7. Calculate the NK cell killing rate based on the test results and the effector-target ratio using the following formula:

[0032] Killing efficiency % = {1-(fluorescence detection value of the effect release group-fluorescence detection value of the background group) / (fluorescence detection value of the maximum release group-fluorescence detection value of the background group)}*100%;

[0033] Where:

[0034] Maximum release group fluorescence detection value: refers to the wells of the plate in which only target cells K562-Luc are added;

[0035] Fluorescence detection value of background group: refers to the wells of the plate containing only 100% lysed target cells K562-Luc;

[0036] Fluorescence detection value of effector release group: refers to the wells of the well plate containing target cells K562-Luc and NK cells.

[0037] In step S1 of the above evaluation method, the K562-Luc target cells and NK cells are counted by trypan blue staining, the purpose of which is to remove dead cells or cells with poor activity and select cells with good activity for subsequent test statistics.

[0038] In step S2 of the above evaluation method, K562-Luc target cells and NK cells are centrifuged at 200-600 g for 3-6 min, respectively; within this range of centrifugal force and centrifugation time, any centrifugal force and centrifugation time can be selected, such as 200 g for 6 min, 300 g for 5 min, 400 g for 3 min, 600 g for 3 min, etc.; preferably, 500 g for 5 min.

[0039] In step S3 of the above evaluation method, when the NK cell precipitate and the K562-Luc target cell precipitate are resuspended and diluted separately, the amount of culture medium added when the target cell precipitate is resuspended should be added according to the target cell density of 1000 to 10000 cells / 50 μL, and the amount of culture medium added when the NK cell precipitate is resuspended should be determined according to the target cell density and the effector-target ratio.

[0040] In step S4 of the above evaluation method, the effector-target ratio of NK cells to K562-Luc target cells is E:T=10:1, 5:1, 1:1, 0.5:1, 0.1:1; and the final volume of NK cells and K562-Luc target cells added is 50 μL respectively; in each well of the well plate, the density of K562-Luc target cells is controlled to be 1000-10000 cells / well; the well plate can be a white fluorescence detection plate or a cell culture plate; the number of wells can be 96 wells, 48 ​​wells, 24 wells or 12 wells, selected as needed; the present invention uses a 96-well white fluorescence detection plate; the density of K562-Luc target cells can be any number of cells in the range of 1000-10000 cells / well, such as 1000, 2000, 5000, 8000 or 10000 cells / well, etc., preferably 10000 cells / well.

[0041] In step S5 of the above evaluation method, the luciferin reaction substrate is GMOne-Step luciferase reagent (purchased from Jiman Biotechnology), and the amount of the luciferin reaction substrate added is 100 μL / well.

[0042] In step S6 of the above evaluation method, the fluorescence detection values ​​refer to the maximum release group fluorescence detection value, the background group fluorescence detection value and the effect release group fluorescence detection value in step S7 respectively; these three groups of fluorescence detection values ​​are independently detected for target cells K562-Luc (without lysis), target cells K562-Luc containing 100% lysis or target cells K562-Luc and NK cells mixed cells, that is, the respective detection data are obtained by independently detecting these three groups of cell samples; and then substituting them into the calculation formula of step S7 to calculate the killing rate of NK.

[0043] The technical solution of the present invention is further described in detail below through some specific embodiments.

[0044] Example 1

[0045] The specific steps of the in vitro natural killer cell biological efficacy evaluation method of this embodiment are as follows:

[0046] 1.1. Preparation of K562-Luc target cells: Take stably expressed K562-Luc cells, centrifuge at 500g for 5 min at room temperature, collect cell pellets, resuspend in KBM581 medium, count the number of live K562-Luc cells, and set aside;

[0047] 1.2. Preparation of NK effector cells: Take the NK cells with identification number Donor 1, centrifuge at 500g for 5 minutes at room temperature, collect the cell pellet, resuspend in KBM581 medium, count the number of live NK cells, and set aside;

[0048] 1.3. Co-culture of effector cells and target cells: Use a 96-well white fluorescent detection plate, add 10,000 target cells to each well and set the volume of each well to 50 μL, that is, control the target cell density to 10,000 / 50 μL / well; set the effector-target ratio to 10:1, 5:1, 1:1, 0.5:1, and 0.1:1; the final volume of NK cells added is 50 μL, the co-culture volume of NK effector cells and K562-Luc target cells is 100 μL, and 3 replicates are set for each group; NK cells labeled with Donor 1 are simultaneously subjected to parallel experiments on 3 96-well white fluorescent detection plates, which are labeled as parallel plate 1, parallel plate 2, and parallel plate 3 respectively;

[0049] 1.4. Transfer the white fluorescent detection plate with added cells to a 37°C, 5% CO2 incubator and incubate for 4 hours;

[0050] 1.5. After the incubation is completed, take out the white fluorescence detection plate, add 100 μL of GMOne-Step luciferase reagent to each well, and incubate at room temperature away from light for 7 minutes; during the incubation process away from light, turn on the microplate reader at the same time, and after the instrument passes the self-test, select the emission wavelength of 570 nm and the mode of shaking the detection plate before reading;

[0051] 1.6. After incubation, read the chemiluminescence value on the machine;

[0052] 1.7. According to the test reading results, the NK cell killing rate is calculated using the above NK killing rate calculation formula, as follows:

[0053] The chemiluminescence values ​​detected by parallel plate 1, parallel plate 2 and parallel plate 3 are shown in Tables 1, 3 and 5 respectively; the killing rates calculated based on the chemiluminescence values ​​are shown in Tables 2, 4, 6 and Figure 2 , 3 , 4; among them, the data in Tables 2, 4, and 6 are respectively Figure 2 , 3 , 4 are consistent; Table 7 is a summary comparison table of the data in parallel plates 1, 2, and 3. Figure 5 is a comparison chart of the killing rates in parallel plates 1, 2, and 3; Table 7 and Figure 5 The data are consistent.

[0054] Table 1 Donor 1NK killing detection parallel plate 1 chemiluminescence value table

[0055]

[0056] The kill rate is calculated based on Table 1 and the results are shown in Table 2.

[0057] Table 2 Donor 1NK parallel plate 1 kill rate calculation results

[0058] Effect-target ratio 0.1:1 0.5:1 1:1 5:1 10:1 Kill rate 19.70% 56.19% 73.15% 98.71% 98.93%

[0059] From Table 2 and Figure 2 It can be seen that in parallel plate 1, when the effector-target ratio was 10:1, 5:1, 1:1, 0.5:1, and 0.1:1, the killing rate of Donor 1 NK cells decreased from 98.93% to 19.70%.

[0060] Table 3 Donor 1NK killing detection parallel plate 2 chemiluminescence value table

[0061]

[0062] The kill rate is calculated based on Table 3 and the results are shown in Table 4.

[0063] Table 4 Donor 1NK parallel plate 2 kill rate calculation results

[0064] Effect-target ratio 0.1:1 0.5:1 1:1 5:1 10:1 Kill rate 14.48% 46.98% 84.21% 98.65% 99.31%

[0065] From Table 4 and Figure 3 It can be seen that in parallel plate 2, when the effector-target ratio was 10:1, 5:1, 1:1, 0.5:1, and 0.1:1, the killing rate of Donor 1 NK cells decreased from 99.3% to 14.48%.

[0066] Table 5 Donor 1NK killing detection parallel plate 3 chemiluminescence value table

[0067]

[0068] The kill rate was calculated based on Table 5 and the results are shown in Table 6.

[0069] Table 6 Donor 1NK parallel plate 3 kill rate calculation results

[0070] Effect-target ratio 0.1:1 0.5:1 1:1 5:1 10:1 Kill rate 23.11% 56.41% 91.80% 98.30% 99.02%

[0071] From Table 6 and Figure 4 It can be seen that in parallel plate 3, when the effector-target ratio was 10:1, 5:1, 1:1, 0.5:1, and 0.1:1, the killing rate of Donor 1 NK cells decreased from 99.02% to 23.11%.

[0072] Relative to the above-mentioned killing rate analysis between NK cell parallel plates 1-3, the analysis results are shown in Table 7:

[0073] Table 7 Statistics of the repeatability of the killing rate between Donor 1NK parallel plates 1 to 3

[0074]

[0075] From Tables 1 to 7 and Figures 2 to 5From the comprehensive data analysis, it can be seen that: 1) the change in NK killing rate of donor 1 in parallel plates 1-3 is positively correlated with the gradient of the effect-target ratio, and the data show that the detection sensitivity of this method is high; 2) there are differences in the biological efficacy of NK in different parallel plates, and the constructed K562-Luc target cells can effectively detect the biological efficacy of NK in the effect-target ratio range of 0.1:1 to 10:1; therefore, the detection method provided by the present invention can stably and effectively detect the tumor inhibition effect of NK cells in vitro, and has high repeatability and reliable data. The killing rate is consistent with the change trend of the effect-target ratio, and the corresponding evaluation of the biological efficacy of NK cells can be achieved.

[0076] Example 2

[0077] In this example, the 96-well white fluorescence detection plate used is the same as the parallel plate 1 in Example 1, and the biological activity of NK cells from different sources is evaluated. The specific steps are as follows:

[0078] 2.1. Collection of K562-Luc target cells: Take stably expressed K562-Luc cells, centrifuge at 300g for 6 min at room temperature, collect cell pellets, resuspend in KBM581 medium, count the number of live K562-Luc cells, and set aside;

[0079] 2.2. Preparation of NK cells: Take NK cells from three different sources, identified as Donor 2, Donor 3, and Donor 4, centrifuge at 300g for 6 min at room temperature, collect the cell pellets, resuspend them in KBM581 medium, count the number of live NK cells, and set aside;

[0080] 2.3. Co-culture of effector cells and target cells: A 96-well white fluorescent detection plate was used, 5000 target cells were added to each well and the volume of each well was 50 μL, that is, the target cell density was controlled to be 5000 / 50 μL / well; the effector-target ratio was set to 10:1, 5:1, 1:1, 0.5:1, and 0.1:1; the final volume of NK cells added was 50 μL, the co-culture volume of NK effector cells and K562-Luc target cells was 100 μL, and 3 replicate wells were set for each group; NK cells labeled with Donor 2, Donor 3, and Donor 4 were co-cultured with target cells of the same culture conditions and the same passage to detect the applicability of this method;

[0081] 2.4. The white fluorescent detection plate with added cells was transferred to an incubator at 37°C and 5% carbon dioxide concentration and incubated for 4 hours;

[0082] 2.5. After the incubation is completed, take out the white fluorescence detection plate, add 100 μL of GMOne-Step luciferase reagent to each well, and incubate at room temperature away from light for 7 minutes; during the incubation process away from light, turn on the microplate reader at the same time, and after the instrument passes the self-test, select the emission wavelength of 570 nm and the mode of shaking the detection plate before reading;

[0083] 2.6. After incubation, read the chemiluminescence value on the machine;

[0084] 2.7. According to the test reading results, the NK cell killing rate is calculated using the above NK killing rate calculation formula, as follows:

[0085] In this embodiment, the chemiluminescence values ​​detected by the NK cells labeled Donor 2, Donor 3, and Donor 4 are shown in Tables 8, 10, and 12, respectively, and the calculated killing rates are shown in Tables 9, 11, 13, and Figure 6 , 7 , 8; among them, the data in Tables 9, 11, and 13 are respectively Figure 6 , 7 , 8 are consistent.

[0086] Table 8 Chemiluminescence value of Donor 2NK killing detection

[0087]

[0088] The kill rate was calculated based on Table 8 and the results are shown in Table 9.

[0089] Table 9 Donor 2NK kill rate calculation results

[0090] Effect-target ratio 0.1:1 0.5:1 1:1 5:1 10:1 Kill rate -7.18% 32.86% 40.27% 94.64% 98.55%

[0091] From Table 9 and Figure 6 It can be seen that when the effector-target ratio is 10:1, 5:1, 1:1, 0.5:1, and 0.1:1, the killing rate of Donor 2 NK cells decreases from 98.55% to -7.81%.

[0092] Table 10 Chemiluminescence value of Donor 3NK killing detection

[0093]

[0094] The kill rate structure calculated according to Table 10 is shown in Table 11.

[0095] Table 11 Donor 3NK kill rate calculation results

[0096] Effect-target ratio 0.1:1 0.5:1 1:1 5:1 10:1 Kill rate -46.19% -24.02% 8.69% 60.69% 95.12%

[0097] From Table 11 and Figure 7It can be seen that when the effector-target ratio is 10:1, 5:1, 1:1, 0.5:1, and 0.1:1, the killing rate of Donor3NK cells decreases from 95.12% to -46.19%.

[0098] Table 11 Chemiluminescence values ​​of Donor 4NK killing detection

[0099]

[0100] The kill rate structure calculated according to Table 10 is shown in Table 11.

[0101] Table 13 Donor 4NK kill rate calculation results

[0102] Effect-target ratio 0.1:1 0.5:1 1:1 5:1 10:1 Kill rate 4.56% 13.85% 38.42% 81.03% 93.91%

[0103] From Table 13 and Figure 8 It can be seen that when the effector-target ratio is 10:1, 5:1, 1:1, 0.5:1, and 0.1:1, the killing rate of Donor3NK cells decreases from 93.91% to 4.56%.

[0104] From Table 8-13 and Figure 6-8 Comprehensively speaking, the changes in NK killing rate of donor 2-4 were positively correlated with the gradient of effector-target ratio, and the data showed that this method had high detection sensitivity, and the biological efficacy of NK from different donors was different. The constructed K562-Luc target cells could effectively detect the biological efficacy of NK within the effector-target ratio range of 0.1:1 to 10:1, and at the same time, the growth inhibition and killing ability of NK on target cells could be evaluated in vitro, providing reliable data reference for subsequent research and development.

[0105] It should be understood that the above description of the preferred embodiments of the present invention is relatively detailed and cannot be regarded as limiting the scope of patent protection of the present invention. The scope of patent protection of the present invention shall be based on the attached claims.

Claims

1. A method for evaluating the biological efficacy of NK cells using fluorescence detection and effector-target ratio, characterized in that: The K562-Luc target cells were mixed and cultured with NK cells; after the culture, the luciferin reaction substrate was added for incubation; after the incubation, the biological efficacy of the NK cells was evaluated by detecting the fluorescence detection value and combining the effector-target ratio.

2. The method for evaluating the biological efficacy of NK cells using fluorescence detection and effector-target ratio according to claim 1, characterized in that: Before mixing target K562-Luc cells with NK effector cells, the following treatments are required: NK cells and K562-Luc target cells were centrifuged at 200-600 g for 3-6 min at room temperature; After centrifugation, the NK cell precipitate and K562-Luc target cell precipitate were collected, and each was resuspended and diluted with KBM581 medium to obtain respective cell suspensions; The NK cell suspension and K562-Luc target cell suspension were added to the wells of the well plate according to the set effector-target ratio and placed in an incubator at 37° C. and 5% CO 2 for co-culture for 3 to 8 hours.

3. The method for evaluating the biological efficacy of NK cells using fluorescence detection and effector-target ratio according to claim 2, characterized in that: When the NK cell suspension and the K562-Luc target cell suspension were added to the well plate, the K562-Luc target cell density was controlled to be 1000-10000 cells / well; and the effector-target ratio was set to 10:1, 5:1, 1:1, 0.5:1 and 0.1:

1.

4. The method for evaluating the biological efficacy of NK cells using fluorescence detection and effector-target ratio according to claim 3, characterized in that: When the NK cell suspension and K562-Luc target cell suspension were added to the well plate for co-culture, the final volume in each well was 50 μL.

5. The method for evaluating the biological efficacy of NK cells using fluorescence detection and effector-target ratio according to claim 1, characterized in that: The luciferin reaction substrate was GMOne-Step luciferase reagent, and the added amount was 100 μL / well.

6. The method for evaluating the biological efficacy of NK cells using fluorescence detection and effector-target ratio according to claim 1, characterized in that: The fluorescence detection value was obtained by using an enzyme-labeled instrument at a wavelength of 570 nm.

7. The method for evaluating the biological efficacy of NK cells using fluorescence detection and effector-target ratio according to claim 1, characterized in that: The step of evaluating the biological efficacy of NK cells by detecting the fluorescence detection value also includes the following processing steps: After the incubation, the fluorescence detection value was read on the microplate reader at a wavelength of 570 nm; The killing rate of NK cells is calculated by combining the fluorescence detection value with the following formula to evaluate the biological efficacy of NK cells; Killing efficiency % = {1-(fluorescence detection value of the effect release group-fluorescence detection value of the background group) / (fluorescence detection value of the maximum release group-fluorescence detection value of the background group)}*100%; Where: Maximum release group fluorescence detection value: refers to the wells of the plate in which only target cells K562-Luc are added; Fluorescence detection value of background group: refers to the wells of the plate containing only 100% lysed target cells K562-Luc; Fluorescence detection value of effector release group: refers to the wells of the well plate containing a mixture of target cells K562-Luc and NK cells.

Citation Information

Cited By

  • Method for detecting killing activity of immune cells, product and application

    CN120314185A